FDA Inspection 1064850 — Mikart LLC
The FDA completed an inspection of Mikart LLC on August 23, 2018 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)